🇫🇷 National study of an artificial intelligence tool used for rare disease screening
Nov 16, 2022 | 2:00 PM CET - 2:10 PM CET
Nov 16, 2022 | 2:00 PM CET - 2:10 PM CET
Description
Varying from a few months to several years, diagnostic errancy is one of the major burdens of rare diseases. This delay in patient management has serious consequences on the chances of therapeutic success and the quality of life of patients. Recent advances in artificial intelligence and innovations in diagnostic assistance bring immense hope for the early identification of these pathologies.
A collaboration between three healthcare institutions, two startups and an association, highlights the interest of developing and deploying on a large scale diagnostic assistance tools based on artificial intelligence to improve screening and patient management.
